SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN)
Clinical trials for SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN) explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN) trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope drug enters human testing for ten types of advanced cancer
Disease control Recruiting nowThis is the first human study of an experimental drug called SLV-154 for people with advanced solid tumors that have spread. The main goal is to find the highest safe dose and understand how the body processes the drug. About 70 adults with one of ten specific advanced cancers wh…
Matched conditions: SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN)
Phase: PHASE1 • Sponsor: Solve Therapeutics • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
New radiation tech aims to save saliva glands, fight dry mouth in cancer patients
Symptom relief Recruiting nowThis study is testing whether a more precise, daily-adjusted radiation therapy can better protect the saliva glands during head and neck cancer treatment. It aims to reduce the severe dry mouth that is a common and debilitating side effect. About 50 patients will be randomly assi…
Matched conditions: SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN)
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Mar 27, 2026 12:38 UTC
-
Sound waves target brain to ease worst cancer pain
Symptom relief Recruiting nowThis study is testing a new, non-surgical procedure to relieve severe pain in people with head, neck, or shoulder cancer. The procedure uses focused sound waves, guided by an MRI, to target a tiny area in the brain involved in pain signaling. Researchers want to see if this is sa…
Matched conditions: SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN)
Phase: NA • Sponsor: University of Virginia • Aim: Symptom relief
Last updated Mar 03, 2026 14:07 UTC